Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Ochsner Health System
- Study ID
- NCT06920563
- Status
- Recruiting
Conditions
- Gestational Hypertension
- Pre-Eclampsia; Complicating Pregnancy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Video — OTHERThose in the intervention arm will watch a short educational video.
- Text Reminder — OTHERThose in the intervention group will receive regular text message reminders to check their blood pressures
- Blood pressure threshold — OTHERThose in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards
Study Details
The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum
Key Dates
- Start date
- Mar 17, 2025
- Status verified
- Apr 2025
- Primary completion
- Oct 16, 2026
- Completion
- Oct 16, 2026
Study Design
- Enrollment
- 296 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: InterventionThis group will watch an education video, receive text message updates, and have their blood pressure medications titrated to a lower BP goal.
- No Intervention: ControlThis group will receive usual post partum care from their obstetrician
Primary Outcome Measure
Engagement [ Time Frame: 6 weeks ]
Central Contacts
- Salima Qamruddin, MD+1 (504) 842-4135
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ochsner Baptist | New Orleans | Louisiana | 70115 | Salima Qamruddin (PRINCIPAL_INVESTIGATOR) Frank Williams, MD (SUB_INVESTIGATOR) Talia Suner, MD (SUB_INVESTIGATOR) Koyenum Obi, MD (SUB_INVESTIGATOR) Keira Barker, MD (SUB_INVESTIGATOR) Daniel Morin, MD (SUB_INVESTIGATOR) |
Find similar trials in New Orleans, LA
Related Studies
- The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Treatment With Aspirin After Preeclampsia: TAP TrialPHASE4 · Recruiting · Malamo Countouris · Pittsburgh, Pennsylvania
- Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIALPHASE4 · Recruiting · Ohio State University · Birmingham, Alabama
- AtorvaStatin Postpartum and Reduction of Cardiovascular risKPHASE4 · Recruiting · Ohio State University · Columbus, Ohio